Skip to main navigation Skip to search Skip to main content

Combination of the mTOR inhibitor rapamycin and CC-5013 has synergistic activity in multiple myeloma

  • Noopur Raje
  • , Shaji Kumar
  • , Teru Hideshima
  • , Kenji Ishitsuka
  • , Dharminder Chauhan
  • , Constantine Mitsiades
  • , Klaus Podar
  • , Steven Le Gouill
  • , Paul Richardson
  • , Nikhil C Munshi
  • , David I Stirling
  • , Joseph H Antin
  • , Kenneth C Anderson

Research output: Journal article (peer-reviewed)Journal article

Fingerprint

Dive into the research topics of 'Combination of the mTOR inhibitor rapamycin and CC-5013 has synergistic activity in multiple myeloma'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology